When Will Intel Rebound?

CANADA - 2025/05/26: In this photo illustration, the Intel Corporation logo is seen displayed on a ... More smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)
Intel (NASDAQ:INTC) stock jumped by nearly 8% during Tuesday's trading session. While there weren't many stock-specific factors to justify such a significant move, tech stocks overall have been on an upward trend, driven by positive sentiment regarding the generative artificial intelligence phenomenon. Additionally, U.S. and Chinese officials are currently engaged in trade discussions in London, reportedly touching on export restrictions for various products, including semiconductors and rare earth metals, which may have contributed to the rise in Intel stock. Furthermore, strong fund inflows into technology funds like the Invesco QQQ Trust during the month of May also reflect the favorable outlook for the sector.
Intel's stock has faced pressure over the past year due to its substantial investments in the foundry sector and a loss of market share in the server and PC spaces to competitors like AMD. Our evaluation of Intel based on essential metrics of Growth, Profitability, Financial Stability, and Downturn Resilience indicates that the company is experiencing poor operating performance, as outlined below. Nevertheless, if you are looking for potential upside with reduced volatility compared to individual stocks, the Trefis High Quality portfolio offers an alternative that has surpassed the S&P 500, yielding returns of over 91% since its launch.
Based on your expenditure per dollar of sales or profit, INTC stock appears inexpensive when contrasted with the broader market.
• Intel possesses a price-to-sales (P/S) ratio of 1.7 versus a figure of 3.0 for the S&P 500
• Moreover, the company's price-to-free cash flow (P/FCF) ratio stands at 8.6 against 20.5 for S&P 500
Intel's Revenues have decreased in the past few years.
• Intel has experienced a decline in its top line at an average rate of 11.2% over the last 3 years (in comparison to a growth of 5.5% for S&P 500)
• Its revenues have dropped by 4.0% from $55 Bil to $53 Bil in the past 12 months (while S&P 500 grew by 5.5%)
• Additionally, its quarterly revenues contracted by 0.4% to $13 Bil in the most recent quarter from $13 Bil a year ago (versus a 4.8% increase for S&P 500)
Intel's profit margins are significantly worse than most companies in the Trefis coverage universe.
• Intel's Operating Income for the last four quarters amounted to $-4.1 Bil, reflecting a very poor Operating Margin of -7.8% (in contrast to 13.2% for S&P 500)
• Intel's Operating Cash Flow (OCF) during this period was $10 Bil, indicating a moderate OCF Margin of 19.5% (against 14.9% for S&P 500)
• For the last four-quarter span, Intel's Net Income was $-19 Bil, signifying a very poor Net Income Margin of -36.2% (compared to 11.6% for S&P 500)
Intel's balance sheet appears to be adequate.
• Intel's debt stood at $50 Bil at the conclusion of the most recent quarter, while its market capitalization is $96 Bil (as of 6/10/2025). This indicates a poor Debt-to-Equity Ratio of 56.3% (compared to 19.9% for S&P 500). [Note: A low Debt-to-Equity Ratio is preferable]
• Total assets for Intel amount to $192 Bil, with cash (inclusive of cash equivalents) comprising $21 Bil. This results in a strong Cash-to-Assets Ratio of 10.9% (in contrast to 13.8% for S&P 500)
INTC stock has performed worse than the benchmark S&P 500 index during some recent downturns. Concerned about the effects of a market crash on INTC stock? Our dashboard How Low Can Intel Stock Go In A Market Crash? offers a thorough analysis of how the stock reacted during and after prior strong market downturns.
• INTC stock experienced a 63.3% decline from a peak of $68.26 on April 9, 2021, to $25.04 on October 11, 2022, compared to a peak-to-trough drop of 25.4% for the S&P 500
• The stock has not yet returned to its pre-Crisis high
• Since then, the highest point the stock has reached is 50.76 on December 27, 2023, and it currently trades at approximately $22
• INTC stock declined by 34.8% from a high of $68.47 on January 24, 2020, to $44.61 on March 16, 2020, versus a peak-to-trough decline of 33.9% for the S&P 500
• The stock has not yet returned to its pre-Crisis high
• INTC stock saw a decrease of 56.8% from a high of $27.98 on December 6, 2007, to $12.08 on February 23, 2009, compared to a peak-to-trough decline of 56.8% for the S&P 500
• The stock fully recovered to its pre-Crisis peak by March 26, 2012
Currently, Intel's recent performance has been lackluster, exhibiting inadequate growth and profitability as well as low resilience in downturns. Nonetheless, looking forward, there is potential for improvement. Intel's foundry operations, previously a weak area, may experience a turnaround within the next two years with the introduction of its advanced 18A process node, already attracting clients such as Amazon and Microsoft. The company is well-positioned to benefit from the administration in power due to its strong U.S. manufacturing footprint, which aligns with anticipated pro-domestic policy shifts. Furthermore, valuation appears reasonable with a lower price-to-sales and price-to-free cash flow ratio relative to the broader market. Additional advantages include the release of new PC/server chips (Lunar Lake, Arrow Lake) and increasing AI involvement through Gaudi accelerators, which could provide further uplift to the struggling stock.
While investing in Intel stock may carry certain risks, the Trefis Reinforced Value (RV) Portfolio has consistently outperformed its all-cap stocks benchmark (a composite of the S&P 500, S&P mid-cap, and Russell 2000 indices) to deliver robust returns for investors. What accounts for this? The quarterly rebalanced mix of large-, mid-, and small-cap RV Portfolio stocks offered an adaptable strategy to capitalize on positive market conditions while minimizing losses during downturns, as described in RV Portfolio performance metrics.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

The Verge

26 minutes ago

• The Verge

Acer Swift 14 AI review: give it up for the ports

The Acer Swift 14 is all over AI the place. It has powerful chip options, exceptional battery life, and loads of ports for such a portable laptop. The keyboard and trackpad are solid, which is not always a given at any price. But the screen and webcam are mediocre, and the speakers are outright terrible. Battery life, performance, and ports are important, and it makes sense to prioritize those, even if it means cutting costs elsewhere. Those are the kinds of tough tradeoffs that budget laptops have to make. Our review configuration of the Swift 14 AI comes with a Core Ultra 7 Series 2 258V (Lunar Lake) processor, 32GB of RAM, and 1TB SSD at an MSRP of $1,299.99. There are numerous Swift 14 variants, including a $1,199.99 AMD Ryzen AI 9 365 config (which I also tested) and a Qualcomm Snapdragon X Plus / Elite model with a better screen. Acer also makes a 16-inch Intel version with an OLED screen, and it's actually $50 cheaper than the 14 but with less RAM. At 2.95 pounds and 0.63-inches thick, the Swift 14 AI isn't the thinnest or lightest around, but it has four USB ports — two USB-A 3.2 and two USB4 — plus a 3.5mm audio jack and HDMI 2.1. I'm used to thin-and-light laptops in this price range having just a couple USB-C ports, maybe a USB-A or proprietary charging port, and an audio jack. Having all this I/O on a laptop of this size is a treat when you need it. The other big treats, in both the Intel Lunar Lake and AMD Ryzen AI models, are the performance and battery life. Both are great for everyday productivity tasks like running many Chrome tabs, Google Docs editing, lengthy video calls, and frequent use of messaging apps like Slack and Signal. The Intel model is an impressive battery sipper, lasting from sunup to well past sundown under lighter workloads. In our battery rundown test, it lasted nearly 17 hours — matching the 15-inch Lenovo Yoga Slim 7i Aura Edition and beaten only by Arm-based Snapdragon laptops like the new Surface Laptop 13-inch and last year's HP OmniBook X. The AMD Ryzen AI 9 365 version, which is nearly identical to the Intel Lunar Lake except for a different hinge design and color, sacrifices a bit of battery life for the sake of better multi-core and graphics performance. But it can still last through an extra long day of average use and then some, and it still got 15 hours in our battery rundown test. System Acer Swift 14 AI / Intel Core Ultra 7 258V 8C / 32GB / 1TB Acer Swift 14 AI / AMD Ryzen AI 9 365 10C / 32GB / 1TB Microsoft Surface Laptop 13.8-inch / Snapdragon X Plus 10C / 16GB / 512GB MacBook Air 13-inch M4 / 10C / 10C / 16GB / 512GB Geekbench 6 CPU Single 2609 2847 2446 3775 Geekbench 6 CPU Multi 10690 14580 13190 14899 Geekbench 6 GPU (OpenCL) 28984 34638 Not tested 30701 Cinebench 2024 Single 118 112 108 171 Cinebench 2024 Multi 596 897 808 736 PugetBench for Photoshop 6598 6651 5600 10163 Sustained SSD reads (MB/s) 5200.83 6391.16 3663.1 2910.04 Sustained SSD writes (MB/s) 4662.05 5588.75 2478.44 2115.57 The keyboard and trackpad aren't showstoppers, but they're solid. The keyboard feels a little thin, but it has decently sized keycaps with just enough tactile feedback to not feel mushy. The mechanical trackpad is a decent size, clicks easily, and is surprisingly quiet. It has a design in its top-right corner reminiscent of some kind of neural pathway. It glows when the neural processing unit (NPU) is being used, to indicate that it's 'thinking,' but it sometimes lights up unexpectedly during everyday tasks, too. Boot up the Swift 14 AI for the first time and you're met with two of its most readily apparent flaws: a mediocre screen and egregious bloatware. The 14-inch 1920 x 1200 / 60Hz display can reach a bright 400 nits, but it looks a bit low contrast and lacks visual punch. Your eyes may adjust to it, but as soon as you spot a better screen on something like a Surface Laptop or MacBook Air you're reminded of the Swift's shortcomings. The bloatware isn't too hard to stamp out, but it's a bit more invasive than other laptops. You may have wanted Dropbox anyway, but I doubt you want it pestering you with subscription offers as soon as you set up your computer. Then there's the taskbar shortcut to and the pop-ups for Google Play Games and free-to-play dreck. Bloatware is one way to subsidize the price of a laptop and keep the price down, but I'm not sure the Swift 14 AI is cheap enough to justify it. But at least it's easy to uninstall. Unfortunately, you can't uninstall the speakers or the webcam. The two-speaker setup is a crime against music. You're better off cranking the volume on your phone. Zoom and Google Meet calls are somehow always too loud or too quiet — I had to keep changing the volume during meetings to accommodate different people's voices. And the webcam is only a little better. I've seen it render an okay image in bright lighting, but once you're in even slightly lower lighting then it falls apart. Acer's built-in software offers image enhancement, but it just boosts contrast and oversharpens, making everything look crunchy. You can certainly get a worse laptop for more money. But for around the same price, you can get the same or similar processor with a nicer screen, better speakers, and equivalent battery life in Lenovo's Yoga Slim 7i (it's just a touch larger, with a worse trackpad). Or you can spend a little more and get an Asus Zenbook S 14 with an excellent OLED screen and slightly better specs (though one less USB-A port). And if you can work with macOS or Windows on Arm and put up with fewer ports, then the 13-inch MacBook Air M4 or 13-inch Surface Laptop are far better all-around packages for less. Part of me still really likes the Swift 14 AI. Performance and battery life are top notch, the port selection is great for a thin-and-light, and almost everything else is at least decent. If you can get it well below its $1,300 MSRP — say, around $1,000 — the mediocre screen and awful speakers are more forgivable. And it seems to go on sale fairly often. Just don't forget your headphones. 2024 Acer Swift 14 AI (as reviewed) Display: 14-inch (1920 x 1200) 60Hz IPS touchscreen CPU (Intel): Intel Core Ultra 7 258V CPU (AMD): AMD Ryzen AI 9 365 RAM: 32GB LPDDR5X Storage: 1TB Webcam: 2560 x 1440 Connectivity: Wi-Fi 7, Bluetooth 5.4 Ports (Intel): 2x USB-A 3.2, 2x Thunderbolt 4, HDMI 2.1, 3.5mm combo audio jack Ports (AMD): 2x USB-A 3.2, 2x USB4, HDMI 2.1, 3.5mm combo audio jack Weight: 2.95 pounds Dimensions (Intel): 12.3 x 8.71 x 0.63 (thickest point) inches Dimensions (AMD): 12.32 x 8.74 x 0.7 (thickest point) inches Battery (Intel): 65Wh Battery (AMD): 75Wh Price (Intel): $1,299.99 Price (AMD): $1,199.99 Photography by Antonio G. Di Benedetto / The Verge

Yahoo

32 minutes ago

• Yahoo

SoftBank founder proposes $1trn AI and robotics hub in US

SoftBank Group founder Masayoshi Son is pursuing a plan to establish a $1trn industrial complex in Arizona, the US, to create a major hub for AI and robotics manufacturing, reported Bloomberg. The Japanese investment firm has approached Taiwan Semiconductor Manufacturing (TSMC) to play a key role in the project, though the specifics of TSMC's potential involvement remain unclear. The proposed complex, dubbed 'Project Crystal Land,' envisions a high-tech manufacturing hub akin to China's Shenzhen, individuals familiar with the plan told the publication. The park could include production lines for AI-powered industrial robots, they said, though the discussions remain private. SoftBank has also engaged with Samsung Electronics executives to gauge interest, alongside a range of other technology companies, the report added. SoftBank officials have held discussions with US federal and state government officials, including US Secretary of Commerce Howard Lutnick, to explore potential tax incentives for companies investing in the industrial park. Son has compiled a list of SoftBank Vision Fund portfolio companies, such as robotics firm Agile Robots SE, that could establish production facilities at the site. The project's feasibility depends on support from the Trump administration and state authorities. While the envisioned cost could reach $1trn, as previously reported by the Nikkei, the actual scale will hinge on participation from major technology firms, Bloomberg's report said. If successful, Son has suggested the possibility of developing additional advanced industrial parks across the US. TSMC, which has already begun mass production at its first Arizona factory as part of a $165bn US investment, indicated that SoftBank's project does not impact its existing plans in Phoenix. Representatives from SoftBank, TSMC, and Samsung declined to comment, and the US Commerce Department did not immediately respond to Bloomberg's inquiries. In March 2025, SoftBank agreed to acquire Ampere Computing, a US-based semiconductor design company, for $6.5bn. As per the deal, Ampere Computing will be acquired by SBG through its subsidiary Silver Bands 6 (US) Corp. Ampere Computing is engaged in developing high-performance, energy-efficient processors tailored for cloud computing and AI workloads. The company currently employs approximately 1000 engineers. "SoftBank founder proposes $1trn AI and robotics hub in US" was originally created and published by Verdict, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Yahoo

40 minutes ago

• Yahoo

Public companies account for 71% of Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) ownership, while individual investors account for 19%

The considerable ownership by public companies in Gyre Therapeutics indicates that they collectively have a greater say in management and business strategy 71% of the company is held by a single shareholder (GNI Group Ltd.) Ownership research, combined with past performance data can help provide a good understanding of opportunities in a stock AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. If you want to know who really controls Gyre Therapeutics, Inc. (NASDAQ:GYRE), then you'll have to look at the makeup of its share registry. With 71% stake, public companies possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk). Individual investors, on the other hand, account for 19% of the company's stockholders. In the chart below, we zoom in on the different ownership groups of Gyre Therapeutics. See our latest analysis for Gyre Therapeutics Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index. Institutions have a very small stake in Gyre Therapeutics. That indicates that the company is on the radar of some funds, but it isn't particularly popular with professional investors at the moment. If the business gets stronger from here, we could see a situation where more institutions are keen to buy. We sometimes see a rising share price when a few big institutions want to buy a certain stock at the same time. The history of earnings and revenue, which you can see below, could be helpful in considering if more institutional investors will want the stock. Of course, there are plenty of other factors to consider, too. We note that hedge funds don't have a meaningful investment in Gyre Therapeutics. GNI Group Ltd. is currently the largest shareholder, with 71% of shares outstanding. This implies that they have majority interest control of the future of the company. Meanwhile, the second and third largest shareholders, hold 3.1% and 3.1%, of the shares outstanding, respectively. Songjiang Ma, who is the third-largest shareholder, also happens to hold the title of Member of the Board of Directors. Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. While there is some analyst coverage, the company is probably not widely covered. So it could gain more attention, down the track. The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group. We can see that insiders own shares in Gyre Therapeutics, Inc.. In their own names, insiders own US$53m worth of stock in the US$755m company. It is good to see some investment by insiders, but it might be worth checking if those insiders have been buying. The general public, who are usually individual investors, hold a 19% stake in Gyre Therapeutics. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders. It appears to us that public companies own 71% of Gyre Therapeutics. It's hard to say for sure but this suggests they have entwined business interests. This might be a strategic stake, so it's worth watching this space for changes in ownership. It's always worth thinking about the different groups who own shares in a company. But to understand Gyre Therapeutics better, we need to consider many other factors. Like risks, for instance. Every company has them, and we've spotted 2 warning signs for Gyre Therapeutics (of which 1 makes us a bit uncomfortable!) you should know about. If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio